Breaking News
September 22, 2018 - Finding epigenetic signature appears to predict inflammation risk in serious type of IBD
September 22, 2018 - Researchers develop light-based technique to measure very weak magnetic fields
September 22, 2018 - UAB researchers study dysfunction of the immune system associated with NSAID carprofen
September 22, 2018 - QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening
September 22, 2018 - Cardiac MR With Contrast Feasible in Developing World
September 22, 2018 - Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people
September 21, 2018 - Children with asthma found to be disadvantaged in education and future occupation
September 21, 2018 - Interaction of chemical slurry and ancient shale in fracking wastewater causes radioactivity
September 21, 2018 - Researchers find that sample size is key factor determining accuracy of study results
September 21, 2018 - Study shows how the drive to eat overpowers the brain’s signal to stop
September 21, 2018 - 30 Million Americans Now Have Diabetes
September 21, 2018 - Thousands of breast cancer gene variants engineered and analyzed
September 21, 2018 - The current fellowship interview process is cumbersome — Stanford researchers have a better idea
September 21, 2018 - Progenitor cells for human bone and cartilage have been identified
September 21, 2018 - Study reveals new therapeutic target for pediatric tumor-associated intractable epilepsy
September 21, 2018 - SLU’s College professor receives NIH grant to develop I-TEST project
September 21, 2018 - DermTech completes enrollment in clinical study to assess DNA damage and reversal
September 21, 2018 - Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness
September 21, 2018 - NIH and FDA call for eliminating involvement of RAC in human gene therapy experiments
September 21, 2018 - New system uses algorithm to convert 2D videos into 3D printed ‘motion sculptures’
September 21, 2018 - Sea squirt model reveals key molecules in dopaminergic neuron differentiation
September 21, 2018 - Effective management of neonatal abstinence syndrome requires coordinated ‘cascade of care’
September 21, 2018 - Refugees seek care for wounds of war
September 21, 2018 - Under the sea, in an octopus’ garden on ecstacy
September 21, 2018 - Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort
September 21, 2018 - Giving kids honest information about water consumption may help them make healthy choices
September 21, 2018 - Horwitz Prize Awarded for Work on Hormones
September 21, 2018 - CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients
September 21, 2018 - Scientists discover new molecules that work together to remove unwanted DNA
September 21, 2018 - Dr. Fenella France to deliver 2019 Plenary Lecture
September 21, 2018 - New research finds that MHC-II molecules have more influence on tumors than MHC-I
September 21, 2018 - Researchers study effects of cardiac cycle in simple learning task
September 21, 2018 - FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy
September 21, 2018 - Positive Barhemsys Phase 3 Treatment Data Published in Anesthesia & Analgesia
September 21, 2018 - Celiac Disease Screening: MedlinePlus Lab Test Information
September 21, 2018 - Autism linked to egg cells’ difficulty creating large proteins
September 21, 2018 - Tweaking nuclear pores could provide new avenue to battle against cancer
September 21, 2018 - Experts warn health care providers to slow down in allowing smart pill in patient care settings
September 21, 2018 - MoreGrasp reports breakthrough development of grasp neuroprosthetics activated by thought control
September 21, 2018 - Study reveals new way to target HER2-negative metastatic breast cancer
September 21, 2018 - CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL
September 21, 2018 - Study offers solid link between visceral organs and brain’s reward, motivation system
September 21, 2018 - First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute
September 21, 2018 - New study shows how Ethiopia has managed to achieve extraordinary progress
September 21, 2018 - Choroidal Detachment – The American Society of Retina Specialists
September 21, 2018 - New clinical trial evaluates aesthetic results of conservative surgery in breast cancer
September 21, 2018 - Discovery of a key protein involved in the development of autism
September 21, 2018 - Air pollution appears to be linked to increased risk of developing dementia
September 21, 2018 - Henry Ford Health System receives $600k grant to study genetic makeup of gliomas
September 21, 2018 - Arthritis common in individuals with varying degrees of depression, finds study
September 21, 2018 - Scientist intends to fight pathogenic bacteria with viruses
September 21, 2018 - New research suggests link between PFAS chemicals and hyperthyroidism in pet cats
September 21, 2018 - Multi-year study data shows impact of new soft contact lens to slow myopia progression in children
September 21, 2018 - Neuroscientists identify circuit for brain’s statistical inference about motion
September 21, 2018 - MILabs’ VECTor6 system wins Commercial Innovation Award at WMIC 2018
September 21, 2018 - Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans
September 21, 2018 - 2006 to 2015 Saw Increase in Severe Maternal Morbidity
September 21, 2018 - Similar changes in the brains of patients with ADHD and emotional instability
September 21, 2018 - Cobalt mining in DR Congo takes a high toll on both creuseurs and environment
September 21, 2018 - Eating fatty fish during pregnancy may boost unborn child’s brain development
September 21, 2018 - Study reveals promising new drug candidate to treat acute renal failure
September 21, 2018 - Neural signal that urges to eat overpowers the one that says to stop
September 21, 2018 - Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens
September 21, 2018 - Researchers simulate how different breast tissues respond to heat from MRIs
September 21, 2018 - Despite red flags at surgery centers, overseers award gold seals
September 21, 2018 - Zapping Airway Nerves May Help COPD Patients Breathe
September 21, 2018 - Researchers find answers as to why some people are at risk of gout
September 21, 2018 - Stars of Stanford Medicine: Genetic counseling and compassion
September 21, 2018 - Researchers use reinforcement learning to train gliders to soar like birds
September 21, 2018 - New federally-funded research project could lead to treatments that extend human lifespan
September 21, 2018 - Health insurance ads have shifted over time due to health plans offered via ACA
September 21, 2018 - Use of transcranial electrical stimulation to bolster creativity has far-reaching implications
September 21, 2018 - Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines
September 21, 2018 - Weighing the risks and benefits of drug tapering—two patients, two perspectives
September 21, 2018 - The “exposome” revealed: a barrage of bacteria, chemicals, microscopic animals and more
September 21, 2018 - Top three immune boosting recommendations to ward off freshers’ flu
September 21, 2018 - Young children’s oral microbiota could serve as early indicator for obesity
September 21, 2018 - Older individuals with multiple sclerosis report higher quality of life than younger counterparts
September 21, 2018 - LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
September 21, 2018 - AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress
Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials

Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials

image_pdfDownload PDFimage_print

Action Points

  • Note that this meta-analysis suggests that increased use of guideline-directed medical therapy in patients undergoing PCI compared to CABG might explain part of the observed benefit of the former therapy.
  • Future studies evaluating CABG, in particular, should be sure to capture medication prescriptions and adherence postoperatively.

Adherence to medical therapy for secondary prevention was generally low in trials comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) and may have even inadvertently given stenting an advantage in these clinical studies, according to a meta-analysis of large clinical trials.

Guideline-directed medical therapy (GDMT) in terms of the combination treatment with antiplatelets, beta-blockers, and statins was prescribed to 67% at year 1 after coronary revascularization and 53% at year 5. Compliance fell even lower — 40% at year 1 and 38% at year 5 — when the recommended treatment list included the use of ACE inhibitors or angiotensin receptor blockers (ARBs).

“Despite the compelling benefits demonstrated by GDMT as secondary prevention after coronary revascularization, compliance remains low even in the tightly controlled environment of clinical trials,” Ana-Catarina Pinho-Gomes, MSc, of Oxford’s John Radcliffe Hospital in England, and colleagues wrote in the Feb. 13 issue of the Journal of the American College of Cardiology.

Notably, adherence to the guidelines was consistently lower after CABG than with PCI. “The difference was particularly marked for P2Y12-receptor inhibitors, as dual antiplatelet therapy is formally recommended in the guidelines after PCI,” the researchers noted.

“The better outcomes achieved with CABG versus PCI became less obvious as the compliance with GDMT increased in PCI versus CABG. Therefore, if compliance rates were identical in both groups, the superiority of CABG for major clinical endpoints might have been even more marked, as part of the benefit of PCI might be explained by better compliance with GDMT,” the investigators suggested.

Their meta-analysis included five trials: SYNTAX, FREEDOM, PRECOMBAT, BEST, and EXCEL.

Pinho-Gomes’ group said that the underuse of GDMT, particularly after CABG, may be related to the misconception that the value of maintaining GDMT is reduced once diseased coronary arteries have been mechanically revascularized with either PCI or CABG.

“In keeping with this, medical therapy is often neglected in coronary revascularization trials and hence poorly reported or not even collected at all, as happened in the recent NOBLE trial,” they pointed out.

“From a research perspective, going forward, clinical investigators must direct their energy toward collecting prescription data in [coronary artery disease] trials and strive to implement GDMT for nearly all study subjects. As leaders in the field and frequent co-authors of guideline statements, revascularization trialists have a responsibility to serve as role models in improving GDMT prescription rates,” said Marc Ruel, MD, MPH, of the University of Ottawa Heart Institute in Ontario, and Alexander Kulik, MD, MPH, of Boca Raton Regional Hospital in Florida.

In an accompanying editorial, Ruel and Kulik suggested that this must be done, even if it means providing trial participants with full coverage for secondary prevention therapy. “Ultimately, improving compliance with GDMT both in and out of the clinical trial context will help our patients achieve the highest level of physical health and quality of life after coronary revascularization,” they said.

Pinho-Gomes and colleagues noted that overall compliance with aspirin and statins was high and reasonably stable over time. There were some differences in antiplatelet prescribing patterns — but considering the controversy regarding dual antiplatelet therapy after coronary revascularization, these differences between trials were not unexpected, either.

It was compliance with beta-blockers and ACE inhibitors or ARBs that was low and more variable, ranging from 43% to 80% and 28% to 79%, respectively, in trials.

“One possible explanation is the fact that although the efficacy of antiplatelet agents and statins in reducing cardiovascular events after coronary revascularization has long been recognized, the advantages of other drug classes have been established more recently and may vary according to comorbidities and risk factors,” the authors suggested.

Limitations of the meta-analysis were that it potentially overestimated medication compliance, because prescriptions were analyzed as a surrogate endpoint; that no patient-level data were available for analysis; and that relatively few trials were included.

Pinho-Gomes and Ruel disclosed no conflicts of interest.

Kulik reported research support from AstraZeneca and Pfizer.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-06-02T00:00:00-0400

last updated

Tagged with:

About author

Related Articles